+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Protein Drugs"

Biopharmaceutical Market Outlook to 2029 - Product Thumbnail Image

Biopharmaceutical Market Outlook to 2029

  • Report
  • September 2024
  • 97 Pages
  • Global
From
From
Single-use Technologies for Biopharmaceuticals Market - Product Thumbnail Image

Single-use Technologies for Biopharmaceuticals Market

  • Report
  • November 2024
  • 207 Pages
  • Global
From
From
From
2024 Protein Synthesis Research Review - Product Thumbnail Image

2024 Protein Synthesis Research Review

  • Report
  • March 2025
  • 209 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein. The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more